Der Biomarker Lipoprotein(a) – Lp(a) in der Diagnostik der peripheren arteriellen Verschlusskrankheit
- Alternative title
-
The biomarker lipoprotein(a)—Lp(a) in the diagnostics of peripheral arterial occlusive disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Deutsch
- Bibliographic citation
-
In: Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie, 72.2021, 2, S. 83-88
- Keyword
-
Biomarker
Periphere arterielle Verschlusskrankheit
Arbeitsschutz
Kardiovaskuläre Krankheit
Lipidstoffwechselstörung
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2021
- Creator
- DOI
-
10.1007/s40664-021-00452-8
- URN
-
urn:nbn:de:hebis:30:3-695489
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Oremek, Gerhard
- Passek, Karola
- Dröge, Janis
- Holzgreve, Fabian Christian
- Ohlendorf-Trapp, Daniela Maren
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2021
Other Objects (12)
Der Biomarker Lipoprotein(a) – Lp(a) in der Diagnostik der peripheren arteriellen Verschlusskrankheit
Lipoprotein(a)
Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification
Frequent LPA KIV-2 variants lower lipoprotein(a) concentrations and protect against coronary artery disease
Lipoprotein(a) in nephrological patients
The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A
Lipoprotein(a): from Causality to Treatment
Automated Turbidimetry of Serum Lipoprotein(a)
Therapeutic Potential of Lipoprotein(a) Inhibitors
Therapie der arteriellen Verschlusskrankheit
Lipoprotein(a) - bedeutsam für die kardiovaskuläre Prävention
Untersuchung zur prokoagulatorischen Wirksamkeit des Lipoprotein(a)
Der Biomarker Lipoprotein(a) – Lp(a) in der Diagnostik der peripheren arteriellen Verschlusskrankheit
Lipoprotein(a)
Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification
Frequent LPA KIV-2 variants lower lipoprotein(a) concentrations and protect against coronary artery disease
Lipoprotein(a) in nephrological patients
The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A
Lipoprotein(a): from Causality to Treatment
Automated Turbidimetry of Serum Lipoprotein(a)
Therapeutic Potential of Lipoprotein(a) Inhibitors
Therapie der arteriellen Verschlusskrankheit
Lipoprotein(a) - bedeutsam für die kardiovaskuläre Prävention
Untersuchung zur prokoagulatorischen Wirksamkeit des Lipoprotein(a)
Der Biomarker Lipoprotein(a) – Lp(a) in der Diagnostik der peripheren arteriellen Verschlusskrankheit
Lipoprotein(a)
Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification
Frequent LPA KIV-2 variants lower lipoprotein(a) concentrations and protect against coronary artery disease
Lipoprotein(a) in nephrological patients
The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A
Lipoprotein(a): from Causality to Treatment
Automated Turbidimetry of Serum Lipoprotein(a)
Therapeutic Potential of Lipoprotein(a) Inhibitors
Therapie der arteriellen Verschlusskrankheit
Lipoprotein(a) - bedeutsam für die kardiovaskuläre Prävention